Drug price concentrated in high COGS cell therapies
Some breakthrough drugs, such as autologous cancer cell therapies that use a patient's own immune cells, have very high cost of goods, with a single dose possibly costing $200,000 to $300,000 before R&D recovery, so million-dollar price tags are more reasonable when viewed in context.